Literature DB >> 2494082

Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome.

R T Scott1, J P Toner, S J Muasher, S Oehninger, S Robinson, Z Rosenwaks.   

Abstract

Cycle day 3 basal levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), and estradiol (E2) were measured in 441 patients in 758 consecutive cycles to determine their predictive value for stimulation quality and pregnancy rates in vitro fertilization (IVF). Patients with low basal FSH levels (less than 15 mIU/ml) had higher pregnancy rates per attempt than those with moderate levels (15 to 24.9 mIU/ml), both of which were higher than those with high FSH levels (greater than 25 mIU/ml). Basal LH and E2 values did not improve the predictive value beyond that provided by FSH. Ongoing pregnancy rates per attempt in the low, moderate, and high FSH groups were 17.0%, 9.3%, and 3.6%, respectively (P less than 0.01). The three groups differed significantly in the percentage of patients having two ovaries, the mean number of follicles aspirated per retrieval, the mean number of preovulatory oocytes obtained, and peak E2 values (P less than 0.01). Cycle day 3 FSH levels are predictive of pregnancy outcome and stimulation characteristics in IVF, and may be useful in counseling patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2494082     DOI: 10.1016/s0015-0282(16)60615-5

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  82 in total

1.  Antral follice counts (AFC) predict ovarian response and pregnancy outcomes in oocyte donation cycles.

Authors:  Alaina Vrontikis; Peter L Chang; Peter Kovacs; Steven R Lindheim
Journal:  J Assist Reprod Genet       Date:  2010-05-14       Impact factor: 3.412

2.  Ovarian stimulation for in vitro fertilization in low-responder patients using pulsatile intravenous follicle stimulating hormone.

Authors:  M C Edelstein; R G Brzyski; G S Jones; S J Muasher
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-10

3.  Does the degree of hypothalamic-pituitary-ovarian recovery after oral contraceptive pills affect outcomes of IVF/ICSI cycles receiving GnRH-antagonist adjuvant therapy in women over 35 years of age?

Authors:  Carla Schmitz; Silvina Bocca; Hind Beydoun; Laurel Stadtmauer; Sergio Oehninger
Journal:  J Assist Reprod Genet       Date:  2012-06-23       Impact factor: 3.412

4.  Conversion from assisted reproductive technology to intrauterine insemination in low responders: is it advantageous?

Authors:  John M Norian; Eric D Levens; Kevin S Richter; Eric A Widra; Michael J Levy
Journal:  Fertil Steril       Date:  2010-02-19       Impact factor: 7.329

5.  Impact of body mass index on in vitro fertilization outcomes.

Authors:  John L Frattarelli; Catherine Lee Kodama
Journal:  J Assist Reprod Genet       Date:  2004-06       Impact factor: 3.412

Review 6.  Best practice in primary care pathology: review 4.

Authors:  W S A Smellie; J Forth; S Sundar; E Kalu; C A M McNulty; E Sherriff; I D Watson; C Croucher; T M Reynolds; P J Carey
Journal:  J Clin Pathol       Date:  2006-05-19       Impact factor: 3.411

Review 7.  Cases in primary care laboratory medicine: testing pitfalls and summary of guidance on sex hormone testing.

Authors:  W Stuart A Smellie
Journal:  BMJ       Date:  2007-01-13

8.  Urinary bisphenol A concentrations and ovarian response among women undergoing IVF.

Authors:  E Mok-Lin; S Ehrlich; P L Williams; J Petrozza; D L Wright; A M Calafat; X Ye; R Hauser
Journal:  Int J Androl       Date:  2009-11-30

9.  Do estrogen receptor alpha polymorphisms have any impact on the outcome in an ART program?

Authors:  Elli Anagnostou; Fotodotis Malamas; Despina Mavrogianni; Vasiliki Dinopoulou; Peter Drakakis; Konstantinos Kallianidis; Dimitris Loutradis
Journal:  J Assist Reprod Genet       Date:  2013-03-15       Impact factor: 3.412

Review 10.  What is the best treatment option for infertile women aged 40 and over?

Authors:  Sarah Armstrong; Valentine Akande
Journal:  J Assist Reprod Genet       Date:  2013-03-29       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.